MET and colorectal carcinoma: The development of c-Met-targeting peptide-functionalized perfluoro-15-crown-5-ether nanoparticles (AH111972-PFCE NPs) provides a promising nanoradiographic agent for early monitoring of CRC liver metastases in imaging techniques.